Department of Pharmacology, School of Basic Medical Science, Nanjing Medical University, Nanjing, Jiangsu, China.
Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
J Cell Physiol. 2018 Jun;233(6):4770-4782. doi: 10.1002/jcp.26270. Epub 2018 Jan 15.
Nonalcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease with manifestation of over-accumulation of fat in liver. Increasing evidences indicate that NAFLD may be in part caused by malfunction of very low density lipoprotein (VLDL) secretion. Hepatocyte nuclear factor 4α (HNF4α), a nuclear receptor protein, plays an important role in sustain hepatic lipid homeostasis via transcriptional regulation of genes involved in secretion of VLDL, such as apolipoprotein B (ApoB). However, the exact functional change of HNF4α in NAFLD remains to be elucidated. In the present study, we found that high fat diet (HFD) induced cytoplasmic retention of HNF4α in hepatocytes, which led to down-regulation of hepatic ApoB expression and its protein level in serum, as well as reduced secretion of VLDL. We further revealed that oxidative stress, elevated in fatty liver, was the key factor inducing the cytoplasmic retention of HNF4α in hepatocytes by activating protein kinase C (PKC)-mediated phosphorylation in HNF4α. Thus, our findings reveal a novel mechanism underlying HFD-induced fatty liver that oxidative stress impairs function of HNF4α on ApoB expression and VLDL secretion via PKC activation, eventually promoting fat accumulation in the liver. Therefore, oxidative stress/PKC/HNF4α pathway may be a novel target to treat diet-induced fatty liver.
非酒精性脂肪性肝病(NAFLD)是最常见的慢性肝病,其特征为肝脏脂肪过度蓄积。越来越多的证据表明,NAFLD 部分可能是由于极低密度脂蛋白(VLDL)分泌功能障碍引起的。核受体蛋白肝细胞核因子 4α(HNF4α)通过转录调控参与 VLDL 分泌的基因(如载脂蛋白 B [ApoB]),在维持肝脏脂质稳态方面发挥着重要作用。然而,HNF4α 在 NAFLD 中的确切功能变化仍有待阐明。在本研究中,我们发现高脂肪饮食(HFD)诱导肝细胞中 HNF4α 的细胞质滞留,导致肝脏 ApoB 表达及其在血清中的蛋白水平下调,以及 VLDL 分泌减少。我们进一步揭示,在脂肪肝中升高的氧化应激是通过激活蛋白激酶 C(PKC)介导的 HNF4α 磷酸化,诱导肝细胞中 HNF4α 细胞质滞留的关键因素。因此,我们的研究结果揭示了 HFD 诱导脂肪肝的一种新机制,即氧化应激通过激活 PKC 损害 HNF4α 对 ApoB 表达和 VLDL 分泌的功能,最终促进肝脏脂肪堆积。因此,氧化应激/PKC/HNF4α 通路可能是治疗饮食诱导性脂肪肝的一个新靶点。